On November 1, 2026, the Thoracic Daisease Diagnosis and Treatment Center of Perennial General Hospital Tianjin was officially inaugurated.

The screening and treatment of pulmonary nodules, complex pulmonary lesions, and lung cancer are major public health issues of great concern to the public. In clinical practice, a large number of elderly and high-risk patients have long faced practical difficulties such as highly invasive traditional needle biopsies, long diagnostic cycles, and the need to travel across regions for medical care. At the same time, in the post-treatment rehabilitation stage, there is often a lack of systematic cardiopulmonary rehabilitation support.

The Thoracic Disease Diagnosis and Treatment Center of Perennial General Hospital Tianjin has fully introduced the Anbo.LCEC® Cryo-Immunotherapy Patented Technology System (Patent No.: ZL 201910162165.1), founded by the renowned thoracic surgery expert, Prof. Li Zhong. Utilizing minimally invasive methods such as ultra-low temperature cryobiopsy, this technology allows for precise intervention of lesions under imaging guidance. With its minimally invasive and safe advantages, this technology is particularly suitable for the elderly, those with poor lung function, and patients with multiple small pulmonary nodules, providing a broader range of clinical options for the screening and diagnosis of early-stage pulmonary nodules and lung cancer.

Along with the official opening of the Center, the supporting Cardiopulmonary Rehabilitation Life Center has also been simultaneously put into operation. It provides systematic, professional, and personalized cardiopulmonary function restoration and wellness services for various groups, including those undergoing post-lung surgery rehabilitation, those with cardiopulmonary function impairment, patients with chronic respiratory diseases, individuals experiencing long-term physical weakness and shortness of breath, and those needing chronic lung disease management. As a result, the Center has built a full-cycle system encompassing "Precision Screening - Specialized Diagnosis and Treatment - Postoperative Rehabilitation - Long-term Maintenance," further improving the hospital's comprehensive medical service chain from treatment to rehabilitation.
|
|
|
While perfecting the clinical service system, the Center is also committed to promoting the standardized application of new technologies through academic exchanges. During this event series, the Study Course on Ultra-low Temperature Cryobiopsy Technology—a sub-venue of the China Tumor Prevention and Treatment Conference hosted by the China Medical Education Association—was concurrently held in a hybrid online and offline format. Empowering clinical practice through academics, it further promoted the standardized popularization and clinical application of ultra-low temperature cryobiopsy technology.

The opening of the Center and the appointment of experts is a key layout for the hospital to deeply cultivate medical livelihood and improve the construction of thoracic and pulmonary specialties. At the event, the hospital officially appointed multiple authoritative experts in the thoracic and pulmonary fields, building a high-standard and professional expert matrix for the diagnosis and treatment of thoracic and pulmonary diseases. This has laid a top-tier talent foundation for the Center's clinical diagnosis and treatment, technological innovation, academic construction, and the tackling of intractable cases. The establishment of the Center allows the public in the Beijing-Tianjin-Hebei region to enjoy high-quality thoracic and pulmonary medical resources without traveling long distances. It has also injected new strength into the precise diagnosis, treatment, and rehabilitation of thoracic diseases for patients in the Beijing-Tianjin-Hebei region and at home and abroad.
Rooted in Tianjin and serving the public. In the future, the Thoracic Disease Diagnosis and Treatment Center of Perennial General Hospital Tianjin will continue to integrate high-quality medical resources, deeply cultivate the field of refined diagnosis and treatment of chest diseases, and routinely carry out chest health science popularization, public welfare screening, academic exchanges, and technical training. With professional technology and full-chain services, it will comprehensively protect the respiratory health of patients at home and abroad.
The Mongolia Health Technology Expo 2026 (MHTE 2026) was held in Ulaanbaatar.
On March 31, the 2026 'Yirun Health · Beauty Together' Art Tour · First Exhibition 'Brilliant Spring Awakening' spectacularly opened at Tianjin Pengrui Li Hospital.